Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung Adenocarcinoma

Conclusion: Concurrent treatment with WBRT and ALK-TKI may be associated with acute severe ear toxicity in patients with BMs of ALKr-NSCLC.

Source: In Vivo - December 26, 2019 Category: Research Authors: NAKASHIMA, T., NONOSHITA, T., HIRATA, H., INOUE, K., NAGASHIMA, A., YOSHITAKE, T., ASAI, K., SHIOYAMA, Y. Tags: Clinical Studies Source Type: research